Stereoselective syntheses of substituted pterocarpans with anti-HIV activity, and 5-aza-/5-thia-pterocarpan and 2-aryl-2,3-dihydrobenzofuran analogues

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1755-1769

  Engler, Thomas A ^a   LaTessa, Kenneth O ^a,b   Iyengar, Rajesh ^a   Chai, Wenying ^a   Agrios, Konstantinos ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b Stephens College   (United States)

Author keywords

2 Aryl 2,3 dihydrobenzofurans; Azapterocarpans; HIV; Pterocarpans; Thiapterocarpans

Indexed keywords

ANTIVIRUS AGENT; DIHYDROBENZOFURAN DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

HUMAN IMMUNODEFICIENCY VIRUS; THIA;

EID: 0030272214     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00192-7     Document Type: Article

References (38)

1. 1. For reviews, see (a) Ingham, J.L. In Progress in the Chemistry of Organic Natural Products. Vol. 43; Herz, W.; Grisebach, H.; Kirby, G. W., Eds.; Springer: Wien; 1983; pp 1-266.
2. (b) Dewick, P. M. In The Flavonoids; Harborne, J. B., Ed.; Chapman & Hall: London; 1994; Chapter 5, and previous reviews in this series. See also references cited in refs 2, 4, and 5.
3. 2. Engler, T. A.; Lynch, Jr K. O.; Reddy, J. P.; Gregory, G. S. Bioorg. Med. Chem. Lett. 1993, 3, 1229.
4. 3. (a) Desideri, N.; Conti, C.; Sestili, I.; Tomao, P.; Stein, M. L.; Orsi, N. Antiviral Chem. Chemother. 1992, 3, 195.
5. (b) Hatano, T.; Yasuhara, T.; Miyamoto, K.; Okuda, T. Chem. Pharm. Bull. 1988, 36, 2286.
6. (c) Hatano, T.; Yasuhara, T.; Fukuda, T.; Noro, T.; Okuda, T. Chem. Pharm. Bull. 1989, 37, 3005.
7. (d) For references to reports of antiviral activity of related flavonoids, sec ref 1b.
8. 4. Tökés, A. L.; Antus, S. Liebigs Ann. Chem. 1994, 911.
9. 5. Engler, T. A.; Reddy, J. P.; Combrink, K. D.; Vander Velde, D. J. Org. Chem. 1990, 55, 1248.
10. 6. The quinones were prepared by Fremy's salt oxidation of the corresponding 2-alkoxyphenols. Representative experimental details for the preparation of 5e can be found in the Supplementary Material to ref 7a.
11. 7. (a) Engler, T. A.; Combrink, K. D.; Letavic, M. A.; Lynch, Jr K. O.; Ray, J. E. J. Org. Chem. 1994, 59, 6567.
12. (b) Engler, T. A.; Wei, D.; Letavic, M. A.; Combrink, K. D.; Reddy, J. P. J. Org. Chem. 1994, 59, 6588.
13. (c) Engler, T. A.; Combrink, K. D.; Takusagawa, F. J. Org. Chem. 1990, 55, 5810.
14. (d) Gates, B. D.; Dalidowicz, P.; Tebben, A.; Wang, S.; Swenton, J. S. J. Org. Chem. 1992, 57, 2135.
15. 8. (a) Cacchi, S.; Ciattini, P. G.; Morera, E.; Ortar, G. Tetrahedron Lett. 1986, 27, 5541.
16. (b) For other examples of deoxygenations of pterocarpans via this method, see ref 5.
17. 9. Engler, T. A.; Lynch, Jr K. O.; Reddy, J. P.; Gregory, G. S.; Chu, F.; Schloss, J. V.; Wilson, J. Abstracts of Papers, 207th National Meeting of the American Chemical Society, San Diego, CA; American Chemical Society: Washington, DC, 1994; ORGN 144.
18. 10. Schäfer, W.; Friebe, W. G.; Leinert, H.; Mertens, A.; Poll, T.; Vondersaal, W.; Zilch, H.; Nuber, B.; Ziegler, M. L. J. Med. Chem. 1993, 36, 726.
19. 11. For a preliminary report, (a) Engler, T. A.; Lynch, Jr K. O.; Chai, W.; Meduna, S. P. Tetrahedron Lett. 1995, 36, 2713. See also
20. (b) Engler, T. A.; Chai, W.; Lynch, Jr K. O. Tetrahedron Lett. 1995, 36, 7003. For another approach to 5-azapterocarpans, see ref 4.
21. 12. (a) Büchi, G.; Wüest, H. J. Org. Chem. 1969, 34, 1122.
22. (b) Das, T. K.; Gupta, A. D.; Ghosal P. K.; Dutta, P. C. Indian J. Chem., Sect. B 1976, 14B, 238.
23. 13. McCombie, S. W.; Oritz, C.; Ganguly, A. K. Tetrahedron Lett. 1993, 34, 8033.
24. 14. (a) Speckamp, W. N.; Westra, J. G.; Huisman, H. O. Tetrahedron 1970, 26, 2353.
25. (b) Luttringhaus, A.; Engelhard, M. Chem. Ber. 1960, 93, 1525.
26. (c) Degani, R.; Fochi, R.; Spunta, G. Boll. Sci. Fac. Chem. Ind. Bologna 1966, 24, 75 [Chem. Abs. 63 13198c (1967)].
27. (d) For a review of methods to prepare thiapyrylium ions, see Doddi, G.; Ercolani, G. Adv. Heterocyclic Chem. 1994, 60, 65.
28. (e) For an example of a Ti(IV)-quinone complex acting as a dehydrogenating agent, see ref 7a.
29. 15. (a) Horino, H.; Inoue, N. J. Chem. Soc., Chem. Commun. 1976, 500.
30. (b) Breytenbach, J. C.; Rall, G. J. H.; Roux, D. G. J. Chem. Soc., Perkin Trans 1 1981, 2604.
31. (c) Coelho, A. L.; Vasconcellos, M. L. A. A.; Simas, B. C.; Rabi, J. A.; Costa, P. R. R. Synthesis 1992, 914.
32. (d) Narkhede, D. D.; Iyer, P. R.; Iyer, C. S. R. Tetrahedron 1990, 46, 2031.
33. (e) Narkhede, D. D.; Iyer, P. R.; Iyer, C. S. R. J. Nat. Prod. 1989, 52, 502.
34. (f) For preparation of 29a, see also Whitmore, F. C.; Hanson, E. R. In Org. Synth., Coll. Vol. I; John Wiley: New York, 1941; p 161.
35. (g) Ishiguro, M.; Tatsuoka, T.; Nakatsuka, N. Tetrahedron Lett. 1982, 23, 3859. See also ref 4.
36. 16. For descriptions of instrumentation and purifications of solvents/reagents, see refs 5, 7a.
37. 17. Laatsch, H. Liebigs Ann. Chem. 1980, 1321.
38. 18. Crouse, D. J.; Wheeler, M. M.; Goemann, M.; Tobin, P. S.; Basu, S. K.; Wheeler, D. S. M. J. Org. Chem. 1981, 46, 1814.